$32.71
0.782.44%
At close: Aug 7, 5:00 PM EST
$32.80
0.090.28%
After Hours: 4:09 PM EST
Stoke Therapeutics Inc
STOKNASDAQ
Earnings: Q2 2026 Earnings were released on Mon Aug 3rd, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 5 days agoClick to view the webcast
Stoke Therapeutics Earnings & Forecasts
Stoke Therapeutics (STOK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Stoke Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.78 | $-0.81 | $-0.81 | $-0.58 |
| Actual | $-0.93 | $-0.79 | $-0.97 | $-0.65 |
| Surprise | -19.2% | +2.47% | -19.8% | -12.1% |
| Revenue | ||||
| Estimate | $5.4M | $5.2M | $5.2M | $6.0M |
| Actual | $9.3M | $6.2M | $1.4M | $10.6M |
| Surprise | +73.2% | +20.9% | -72.8% | +76.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.94 | $-0.96 | $-0.96 | $-0.88 |
| Revenue | ||||
| Consensus | $6.9M | $7.0M | — | — |
